Cancer Profiling Market: Next-Generation Sequencing Technique to Generate Significant Revenues Throughout 2026

Dublin 2, Ireland, 2018-Apr-23 — /EPR Network/ — The global market discussion on cancer profiling industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on cancer profiling market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=358

With the growing prevalence of cancer among individuals, research and healthcare institutions are focusing on developing effective medications and therapies. As medications and therapies vary for different cancers, healthcare institutions are focusing on identifying and classifying tumors to develop effective therapies. Through incorporation of innovative solutions and techniques such as cancer profiling, oncologists and researchers can conveniently detect and examine mutations in the DNA sequences. In order to develop enhanced treatment and diagnosis, researchers are conducting gene expression analysis.

Ongoing advancement in biotechnology has enabled researchers to identify and segment tumors on the basis of their molecular profile. As the need to develop effective treatment and medications for different types of cancer arises, leading companies are focusing on identifying tumor-specific gene mutations. Oncologists and researchers are focusing on classifying tumors in terms of abnormality, growth, and spread. In order to offer better patient care, leading companies are focusing on developing tumor-specific therapies and medications.

More Than US$ 120,000 Mn Opportunity in Global Cancer Profiling Market

According to Fact.MR, the global cancer profiling market is expected to reach a value of over US$ 120,000 Mn by 2026-end. Prevalence of cancer among individuals has led to surge in demand for effective medications and therapies. Growing need to conduct research analysis, predict, and identify the molecular profile of tumors has led researchers to conduct cancer profiling techniques. Some of the cancer profiling techniques include immunohistochemistry, microarray, next-generation sequencing, fragment analysis, and pyrosequencing. Through innovative treatment techniques such as next-generation sequencing, researchers and oncologists are focusing on identifying multiple tumor mutations to develop effective therapies. As preference for precision medicine treatment continues to remain high in the healthcare institutions, oncologists are concentrating on adopting various cancer profiling techniques. Also, surge in demand for personalized medicines and point-of-care diagnostic tests has led oncologists and researchers to concentrate on developing tumor-specific treatment techniques and medications. To remain on the forefront of the global market, leading companies are focusing on developing tumor-specific and innovative therapies and medications.

Growing need to identify multiple tumor mutations has to an increase in adoption of next-gen sequencing-based genetic profiling techniques in the healthcare institutions. In terms of revenue, the next-gen sequencing-based genetic profiling techniques is expected to represent the highest growth in the global market by the end of 2026. Adoption of various cancer profiling techniques will continue to remain high for diagnosis purposes. Diagnosis application is expected to generate significant revenues in the global market by the end of 2026.

As the need to offer better-targeted medications and therapies persists, adoption of cancer profiling techniques will continue to remain high in the biotech and pharmaceutical companies. Also, implementation of cancer profiling techniques enables the oncologists to develop correct predictions of different types of cancer and lowers the adverse effects of medications by offering correct formulations and dosages for the treatment process. In terms of revenue, pharmaceutical and biotechnological companies are projected to witness significant revenue growth in the global market by the end of 2026.

Leading players in the global market are Roche Holdings, Caris Life Sciences, GenScript, Illumina, Inc. (U.S.), Proteome Sciences PLC, RiboMed Biotechnologies Inc., BioTheranostics, NeoGenomics Laboratories, Genomic Health Inc., Oxford Gene Technology Ltd., and Agendia.

Browse Full Report with TOC- https://www.factmr.com/report/358/cancer-profiling-market

Table of Content:

1. Global Economic Outlook

2. Global Cancer Profiling Market – Executive Summary

3. Global Cancer Profiling Market Overview
3.1. Introduction
3.1.1. Global Cancer Profiling Market Taxonomy
3.1.2. Global Cancer Profiling Market Definition
3.2. Global Cancer Profiling Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Cancer Profiling Market Y-o-Y Growth
3.3. Global Cancer Profiling Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Characteristics of Molecular Profiling Trials
3.7. Three-Tiered Approach for Reporting Biomarkers in Tumor Profiling NGS Tests
3.8. Recent breakthroughs in Cancer Profiling Market
3.9. Patent Analysis
3.10. Treatment Approvals
3.11. Cancer Epidemiology
3.12. PESTL Analysis
3.13. Product Lifecycle
3.14. Service Provider List
3.15. Key Participants Market Presence (Intensity Map) By Region

4. Global Cancer Profiling Market Analysis and Forecast 2012-2026 
4.1. Global Cancer Profiling Market Size and Forecast By Technique, 2012-2026
4.1.1. Next-Generation Sequencing Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region

Continued….

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=358

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/